The DOI matches its Crossref record; 400 of the 400 references it cites were found in a registry or an index.
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Open accessAbstract
This review provides an update on recent findings from basic, translational, and clinical studies on the molecular mechanisms of mitochondrial dysfunction and apoptosis of hepatocytes in multiple liver diseases, including but not limited to alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and drug-induced liver injury (DILI). While the ethanol-inducible cytochrome P450-2E1 (CYP2E1) is mainly responsible for oxidizing binge alcohol via the microsomal ethanol oxidizing system, it is also responsible for metabolizing many xenobiotics, including pollutants, chemicals, drugs, and specific diets abundant in n-6 fatty acids, into toxic metabolites in many organs, including the liver, causing pathological insults through organelles such as mitochondria and endoplasmic reticula. Oxidative imbalances (oxidative stress) in mitochondria promote the covalent modifications of lipids, proteins, and nucleic acids through enzymatic and non-enzymatic mechanisms. Excessive changes stimulate various post-translational modifications (PTMs) of mitochondrial proteins, transcription factors, and histones. Increased PTMs of mitochondrial proteins inactivate many enzymes involved in the reduction of oxidative species, fatty acid metabolism, and mitophagy pathways, leading to mitochondrial dysfunction, energy depletion, and apoptosis. Unique from other organelles, mitochondria control many signaling cascades involved in bioenergetics (fat metabolism), inflammation, and apoptosis/necrosis of hepatocytes. When mitochondrial homeostasis is shifted, these pathways become altered or shut down, likely contributing to the death of hepatocytes with activation of inflammation and hepatic stellate cells, causing liver fibrosis and cirrhosis. This review will encapsulate how mitochondrial dysfunction contributes to hepatocyte apoptosis in several types of liver diseases in order to provide recommendations for targeted therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MASLD is a progressively worsening liver condition characterized by pathological processes including fat accumulation, cell death, inflammation, and fibrosis within liver cells [68–70].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · cited 2×
“MASLD is closely affiliated with obesity [221, 222], type-2 diabetes mellitus (T2DM) [221, 222], hypertension [221], and metabolic syndrome [221].”
BackgroundInfluentialChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 2×
“According to Day and James, oxidative stress follows steatosis as the “second hit” [230].”
BackgroundNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“However, their histological features and pathological mechanisms are very similar [341]; this is because many metabolic risk factors for MASLD/MASH overlap with those of ALD [342] (and significantly increase the risk of severe liver disease [343]) and patients need to be treated for both types of…”
BackgroundThe multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119 · cited 1×
“…of MASLD detail the role of lipid and sugar metabolism, gut barrier dysfunction, and systemic inflammation as common factors in metabolic syndrome [233] MASLD/MASH, caused by non-alcohol substances, such as fructose/sucrose and Western-style high-fat diets (HFDs) (containing high ratios of…”
BackgroundLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806 · cited 1×
“Excessive oxidative stress may cause DNA oxidation [25], lipid peroxidation, oxidative protein modifications [26], impaired fat metabolism [6, 20, 26–28], systemic inflammation [26, 29, 30], and tissue damage [31–33], all of which contribute to the progression of liver diseases [17, 34, 35].”
BackgroundGlobal burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Transcriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,192 · cited 1×
“The transcription of many of these antioxidants is either regulated by per-oxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) [98] or by nuclear factor erythroid 2-related factor (Nrf2) separating from its regulatory binding protein Kelch-like ECH-associated protein (Keap1) [99, 100].”
Background
Cited by
Role of mitochondria in physiological activities, diseases, and therapy
Wang, L., Zhou, X., & Lu, T. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00284-5 · Cited by 99
“Treatments for mitochondrial related liver disease include the intake of low-calorie diets, antidiabetic drugs, bile acid modulators, antioxidants, mitochondrial uncouplers, and enhanced mitochondrial bioenergetics [189, 199–201].”
Micro/nano plastics in the urinary system: Pathways, mechanisms, and health risks
Huang, H., Lei, P., Yu, H., Du, J., Wu, B., Wang, H., Yang, Q., Cheng, Y., Sun, D., & Wan, L. (2024) · Environment International · doi:10.1016/j.envint.2024.109109 · Cited by 55
CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis
Zhang, Y., Zhang, C., Feng, R., Tong, M., Peng, W. J., Song, J., Ma, W., Xu, W., Chen, X., Chen, J., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01828-y · Cited by 55
“Mitochondria act as "signal amplifiers" for cell apoptosis, influencing apoptosis by regulating the oxidative state within the cell and inter-acting with the endoplasmic reticulum to jointly modulate this process [45, 46].”
BackgroundRoles of Oxidative Stress and Autophagy in Alcohol-Mediated Brain Damage
Ruiter-Lopez, L., Khan, M. A. S., Wang, X., & Song, B. (2025) · Antioxidants · doi:10.3390/antiox14030302 · Cited by 55
“These changes lead to protein post-translational modifications (PTMs), lipid peroxidation products, and DNA-adducts, all of which can potentially contribute to tissue damage, mutagenesis, or carcinogenesis if not treated properly [21].”
Self-citationNewer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Sree, R. R., Kalyan, M., Anand, N., Mani, S., Gorantla, V. R., Sakharkar, M. K., Song, B., & Chidambaram, S. B. (2025) · ACS Omega · doi:10.1021/acsomega.4c05527 · Cited by 55
Self-citation
Metadata
- Authors
- LeFort, K. R., Rungratanawanich, W., & Song, B.-J.
- Affiliations
- National Institutes of Health (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- Corresponding author
- LeFort, Karli R.
- Song, Byoung-Joon
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2024-01-12
- Volume
- 81
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC10786752
- OpenAlex
- W4390790439
- Cited by
- 202
- References
- 399
- Citations by year
- 2026: 88 · 2025: 90 · 2024: 24
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (1 ZIAAA000036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- mitochondrial dysfunction, hepatocyte apoptosis, liver disease, oxidative stress, post-translational modification, CYP2E1, alcoholic liver disease, non-alcoholic fatty liver disease, drug-induced liver injury, intestinal barrier dysfunction, inflammation, liver fibrosis, liver cirrhosis, hepatic stellate cells, mitophagy, bioenergetics, omega-6 fatty acids
- MeSH terms
- Ethanol, Gastrointestinal Diseases, Humans, Inflammation, Liver, Liver Diseases, Alcoholic, Protein Processing, Post-Translational, Apoptosis, Oxidative Stress, Hepatocytes, Mitochondrial Proteins, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. https://app.cochat.ai/papers/10.1007/s00018-023-05061-7
- The paper
- LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024). Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-023-05061-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.